160 related articles for article (PubMed ID: 38164262)
1. Efficient Colon Cancer Immunogene Therapy Through Co-Delivery of IL-22BP mRNA and Tumor Cell Lysate by CLSV Nanoparticles.
Huang J; Wang K; Fu X; Zhu M; Chen X; Gao Y; Ma P; Duan X; Men K
Int J Nanomedicine; 2023; 18():8059-8075. PubMed ID: 38164262
[TBL] [Abstract][Full Text] [Related]
2. Dual-mRNA Delivery Using Tumor Cell Lysate-Based Multifunctional Nanoparticles as an Efficient Colon Cancer Immunogene Therapy.
Wang K; Gao Y; Wu S; Zhang J; Zhu M; Chen X; Fu X; Duan X; Men K
Int J Nanomedicine; 2024; 19():4779-4801. PubMed ID: 38828196
[TBL] [Abstract][Full Text] [Related]
3. Tumor Cell Lysate-Based Multifunctional Nanoparticles Facilitate Enhanced mRNA Delivery and Immune Stimulation for Melanoma Gene Therapy.
Huang J; Wang K; Wu S; Zhang J; Chen X; Lei S; Wu J; Men K; Duan X
Mol Pharm; 2024 Jan; 21(1):267-282. PubMed ID: 38079527
[TBL] [Abstract][Full Text] [Related]
4. Single Micelle Vectors based on Lipid/Block Copolymer Compositions as mRNA Formulations for Efficient Cancer Immunogene Therapy.
Li J; Men K; Gao Y; Wu J; Lei S; Yang Y; Pan H
Mol Pharm; 2021 Nov; 18(11):4029-4045. PubMed ID: 34559545
[TBL] [Abstract][Full Text] [Related]
5. Functionalized DMP-039 Hybrid Nanoparticle as a Novel mRNA Vector for Efficient Cancer Suicide Gene Therapy.
Gao Y; Men K; Pan C; Li J; Wu J; Chen X; Lei S; Gao X; Duan X
Int J Nanomedicine; 2021; 16():5211-5232. PubMed ID: 34366664
[TBL] [Abstract][Full Text] [Related]
6. Delivery of interleukin-22 binding protein (IL-22BP) gene by cationic micelle for colon cancer gene therapy.
Men K; Huang R; Zhang X; Zhang R; Zhang Y; Peng Y; Tong R; Yang L; Wei Y; Duan X
RSC Adv; 2018 May; 8(30):16537-16548. PubMed ID: 35540501
[TBL] [Abstract][Full Text] [Related]
7. Efficient Colorectal Cancer Gene Therapy with IL-15 mRNA Nanoformulation.
Lei S; Zhang X; Men K; Gao Y; Yang X; Wu S; Duan X; Wei Y; Tong R
Mol Pharm; 2020 Sep; 17(9):3378-3391. PubMed ID: 32787272
[TBL] [Abstract][Full Text] [Related]
8. Delivery of a Modified mRNA Encoding IL-22 Binding Protein (IL-22BP) for Colon Cancer Gene Therapy.
Zhang R; Men K; Zhang X; Huang R; Tian Y; Zhou B; Yu C; Wang Y; Ji X; Hu Q; Yang L
J Biomed Nanotechnol; 2018 Jul; 14(7):1239-1251. PubMed ID: 29944098
[TBL] [Abstract][Full Text] [Related]
9. Treating colon cancer with a suicide gene delivered by self-assembled cationic MPEG-PCL micelles.
Duan X; Wang P; Men K; Gao X; Huang M; Gou M; Chen L; Qian Z; Wei Y
Nanoscale; 2012 Apr; 4(7):2400-7. PubMed ID: 22388488
[TBL] [Abstract][Full Text] [Related]
10. Local and Systemic Delivery of Interleukin-12 Gene by Cationic Micelles for Cancer Immunogene Therapy.
Men K; Huang R; Zhang X; Zhang R; Zhang Y; He M; Tong R; Yang L; Wei Y; Duan X
J Biomed Nanotechnol; 2018 Oct; 14(10):1719-1730. PubMed ID: 30041719
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Colon Cancer by Degradable rrPPC Nano-Conjugates Delivered STAT3 siRNA.
Zhang H; Men K; Pan C; Gao Y; Li J; Lei S; Zhu G; Li R; Wei Y; Duan X
Int J Nanomedicine; 2020; 15():9875-9890. PubMed ID: 33324056
[TBL] [Abstract][Full Text] [Related]
12. Small interfering RNA for cancer treatment: overcoming hurdles in delivery.
Charbe NB; Amnerkar ND; Ramesh B; Tambuwala MM; Bakshi HA; Aljabali AAA; Khadse SC; Satheeshkumar R; Satija S; Metha M; Chellappan DK; Shrivastava G; Gupta G; Negi P; Dua K; Zacconi FC
Acta Pharm Sin B; 2020 Nov; 10(11):2075-2109. PubMed ID: 33304780
[TBL] [Abstract][Full Text] [Related]
13. Modified nanoparticle mediated IL-12 immunogene therapy for colon cancer.
Liu X; Gao X; Zheng S; Wang B; Li Y; Zhao C; Muftuoglu Y; Chen S; Li Y; Yao H; Sun H; Mao Q; You C; Guo G; Wei Y
Nanomedicine; 2017 Aug; 13(6):1993-2004. PubMed ID: 28428054
[TBL] [Abstract][Full Text] [Related]
14. Delivery siRNA with a novel gene vector for glioma therapy by targeting Gli1.
Zhou P; Cao Y; Liu X; Yu T; Xu Q; You C; Gao X; Wei Y
Int J Nanomedicine; 2018; 13():4781-4793. PubMed ID: 30214189
[TBL] [Abstract][Full Text] [Related]
15. Targeted MIP-3β plasmid nanoparticles induce dendritic cell maturation and inhibit M2 macrophage polarisation to suppress cancer growth.
He Y; Wang M; Li X; Yu T; Gao X
Biomaterials; 2020 Aug; 249():120046. PubMed ID: 32325346
[TBL] [Abstract][Full Text] [Related]
16. Local and systemic delivery of mRNA encoding survivin-T34A by lipoplex for efficient colon cancer gene therapy.
Zhang X; Men K; Zhang Y; Zhang R; Yang L; Duan X
Int J Nanomedicine; 2019; 14():2733-2751. PubMed ID: 31118608
[No Abstract] [Full Text] [Related]
17. Powerful anti-colon cancer effect of modified nanoparticle-mediated IL-15 immunogene therapy through activation of the host immune system.
Liu X; Li Y; Sun X; Muftuoglu Y; Wang B; Yu T; Hu Y; Ma L; Xiang M; Guo G; You C; Gao X; Wei Y
Theranostics; 2018; 8(13):3490-3503. PubMed ID: 30026861
[No Abstract] [Full Text] [Related]
18. Cationic micelle-based siRNA delivery for efficient colon cancer gene therapy.
Lu Y; Zhong L; Jiang Z; Pan H; Zhang Y; Zhu G; Bai L; Tong R; Shi J; Duan X
Nanoscale Res Lett; 2019 Jun; 14(1):193. PubMed ID: 31165329
[TBL] [Abstract][Full Text] [Related]
19. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
20. Exploration of mRNA nanoparticles based on DOTAP through optimization of the helper lipids.
Ma X; Wu F; Peng C; Chen H; Zhang D; Han T
Biotechnol J; 2023 Nov; 18(11):e2300123. PubMed ID: 37545293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]